Making the most of rodent tumour systems in cancer drug discovery

被引:6
作者
Bibby, MC [1 ]
机构
[1] Univ Bradford, Clin Oncol Unit, Bradford BD7 1DP, W Yorkshire, England
关键词
D O I
10.1038/sj.bjc.6690261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1633 / 1640
页数:8
相关论文
共 79 条
  • [1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
    Arap, W
    Pasqualini, R
    Ruoslahti, E
    [J]. SCIENCE, 1998, 279 (5349) : 377 - 380
  • [2] ATASSI G, 1985, EUR J MED CHEM, V20, P393
  • [3] ATWELL GJ, 1989, ANTI-CANCER DRUG DES, V4, P161
  • [4] TUMOR VASCULATURE - A POTENTIAL THERAPEUTIC TARGET
    BAILLIE, CT
    WINSLET, MC
    BRADLEY, NJ
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 257 - 267
  • [6] POTENTIATION OF EO9 ANTITUMOR-ACTIVITY BY HYDRALAZINE
    BIBBY, MC
    SLEIGH, NR
    LOADMAN, PM
    DOUBLE, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) : 1033 - 1035
  • [7] THE LOGISTICS OF BROADER PRE-CLINICAL EVALUATION OF POTENTIAL ANTI-CANCER AGENTS WITH REFERENCE TO ANTI-TUMOR ACTIVITY AND TOXICITY OF MITOZOLOMIDE
    BIBBY, MC
    DOUBLE, JA
    WAHED, IA
    HIRBAWI, N
    BAKER, TG
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 139 - 143
  • [8] FLAVONE ACETIC-ACID FROM LABORATORY TO CLINIC AND BACK
    BIBBY, MC
    DOUBLE, JA
    [J]. ANTI-CANCER DRUGS, 1993, 4 (01) : 3 - 17
  • [9] Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1
  • [10] BRESALIER RS, 1987, CANCER RES, V47, P1398